Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3526 |
|
| Actual shortage: | 229 (6%) | |
| Anticipated shortage: | 3 (0%) | |
| Avoided shortage: | 11 (0%) | |
| Resolved: | 3283 (93%) | |
Discontinuation Reports |
366 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 342 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
143 (4%) |
|
Overdue reports |
32 (13%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-ATOMOXETINE | 10MG | CAPSULE | Resolved | 2019-08-07 | 2019-09-23 | 91067 |
| APO-ATOMOXETINE | 25MG | CAPSULE | Resolved | 2020-02-13 | 2020-06-08 | 105994 |
| APO-ATOMOXETINE | 40MG | CAPSULE | Resolved | 2020-06-10 | 2020-06-15 | 117339 |
| APO-ATOMOXETINE | 10MG | CAPSULE | Resolved | 2021-01-18 | 2021-03-15 | 131812 |
| APO-ATOMOXETINE | 10MG | CAPSULE | Resolved | 2022-01-07 | 2022-03-28 | 152295 |
| APO-ATOMOXETINE | 40MG | CAPSULE | Resolved | 2022-01-21 | 2022-04-01 | 153262 |
| APO-ATOMOXETINE | 25MG | CAPSULE | Resolved | 2022-02-25 | 2022-03-29 | 155597 |
| APO-ATOMOXETINE | 60MG | CAPSULE | Resolved | 2022-02-25 | 2022-04-01 | 155600 |
| APO-ATOMOXETINE | 40MG | CAPSULE | Resolved | 2023-06-02 | 2023-07-07 | 193600 |
| APO-ATOMOXETINE | 80MG | CAPSULE | Resolved | 2023-07-21 | 2023-08-18 | 199524 |
| APO-ATOMOXETINE | 40MG | CAPSULE | Resolved | 2023-09-15 | 2023-12-01 | 204411 |
| APO-ATOMOXETINE | 40MG | CAPSULE | Resolved | 2023-10-06 | 2023-12-01 | 206566 |
| APO-ATOMOXETINE | 100MG | CAPSULE | Resolved | 2024-05-24 | 2024-10-11 | 228792 |
| APO-ATOMOXETINE | 25MG | CAPSULE | Resolved | 2024-05-30 | 2024-10-04 | 229164 |
| APO-ATOMOXETINE | 40MG | CAPSULE | Resolved | 2024-05-30 | 2024-10-04 | 229167 |
| APO-ATOMOXETINE | 10MG | CAPSULE | Resolved | 2024-07-12 | 2024-09-27 | 232818 |
| APO-ATOMOXETINE | 40MG | CAPSULE | Resolved | 2024-08-01 | 2024-10-04 | 234317 |
| APO-ATOMOXETINE | 25MG | CAPSULE | Resolved | 2024-09-05 | 2024-10-04 | 236872 |
| APO-ATOMOXETINE | 25MG | CAPSULE | Resolved | 2024-11-07 | 2024-12-20 | 242211 |
| APO-ATOMOXETINE | 40MG | CAPSULE | Resolved | 2025-06-19 | 2025-06-27 | 260675 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-LAMIVUDINE | 300MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60560 |
| APO-LAMIVUDINE HBV | 100MG | TABLET | Discontinued | 2018-09-07 | 2019-12-21 | 60563 |
| APO-LATANOPROST-TIMOP | Discontinued | 2018-09-07 | 2018-09-15 | 60572 | ||
| APO-LEVOCARB | 25MG 250MG | TABLET | Discontinued | 2018-09-07 | 2019-02-07 | 60576 |
| APO-LISINOPRIL | 10MG | TABLET | Discontinued | 2018-09-07 | 2019-02-02 | 60579 |
| APO-LISINOPRIL | 20MG | TABLET | Discontinued | 2018-09-07 | 2018-11-26 | 60582 |
| APO-LISINOPRIL | 5MG | TABLET | Discontinued | 2018-09-07 | 2019-02-13 | 60585 |
| APO-LISINOPRIL/HCTZ | 12.5MG 20MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1090 |
| APO-LISINOPRIL/HCTZ | 12.5MG 10MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1093 |
| APO-LISINOPRIL/HCTZ | 25MG 20MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1096 |
| APO-LITHIUM CARBONATE | 300MG | CAPSULE | Discontinued | 2018-09-07 | 2018-09-15 | 60588 |
| APO-LOPERAMIDE | 2MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4930 |
| APO-LORAZEPAM | 0.5MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60591 |
| APO-LORAZEPAM | 1MG | TABLET | Discontinued | 2018-09-07 | 2018-10-05 | 60594 |
| APO-LOSARTAN | 50MG | TABLET | Discontinued | 2018-09-10 | 2018-09-15 | 60987 |
| APO-LOSARTAN | 100MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71213 |
| APO-LOSARTAN | 25MG | TABLET | Discontinued | 2019-02-01 | 2019-02-02 | 74376 |
| APO-LOSARTAN/HCTZ | 12.5MG 100MG | TABLET | Discontinued | 2018-09-07 | 2018-11-02 | 60597 |
| APO-LOSARTAN/HCTZ | 25MG 100MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60600 |
| APO-LOSARTAN/HCTZ | 12.5MG 50MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60603 |